HSA
EVH icon

Hussman Strategic Advisors’s Evolent Health EVH Stock Holding History

Hussman Strategic Advisors’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-105,000
Closed -$994K – 238
2025
Q1 		$994K Buy
105,000
+42,000
+67% +$424K 0.24% 166
2024
Q4 		$709K Buy
+63,000
New +$1.11M 0.21% 163
2022
Q1 		– Sell
-24,800
Closed -$686K – 335
2021
Q4 		$686K Hold
24,800
– – 0.15% 211
2021
Q3 		$769K Sell
24,800
-11,200
-31% -$269K 0.17% 189
2021
Q2 		$760K Hold
36,000
– – 0.16% 220
2021
Q1 		$727K Sell
36,000
-66,000
-65% -$1.26M 0.15% 216
2020
Q4 		$1.64M Buy
+102,000
New +$1.35M 0.43% 89

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Hussman Strategic Advisors's EVH Position: Q2 2025 in Review

Hussman Strategic Advisors sold out of Evolent Health (EVH) in Q2 2025, closing a stake of 105,000 shares — an estimated $994K sold.

Hussman Strategic Advisors first reported a position in EVH in Q4 2020 and held it in 7 quarters. The position peaked at $1.64M in Q4 2020. 220 funds tracked by Wall St. Rank hold EVH as of Q2 2025.

  • Hussman Strategic Advisors reported no remaining Evolent Health position as of Q2 2025 after selling out during the quarter.
  • Hussman Strategic Advisors sold 105,000 Evolent Health shares in Q2 2025, an estimated $994K.
  • Hussman Strategic Advisors first reported a position in Evolent Health in Q4 2020 and held it in 7 quarters.
  • Hussman Strategic Advisors's Evolent Health position peaked at $1.64M in Q4 2020.
  • 220 funds tracked by Wall St. Rank held Evolent Health as of Q2 2025.

Based on Hussman Strategic Advisors's 13F filing for Q2 2025, filed 5 Aug 2025.